One recent analysis found that, over the course of three years, people taking semaglutide (the compound in Ozempic and the weight loss drug Wegovy) were about 40 to 70 percent less likely to be ...

A pathway once considered fundamental in Alzheimer’s disease is being studied intensely again, and may soon result in safer, ...

The Food and Drug Administration (FDA) has approved a new maintenance dosing schedule for Leqembi, a monoclonal antibody ...

A new clinical study has started this week, looking at whether a blood test can help diagnose dementia earlier on.

The U.S. Food and Drug Administration has approved monthly maintenance dosing for Japan's Eisai and partner Biogen's ...

Access to the new Alzheimer's drugs is limited by strict eligibility criteria, long wait times, and a lack of infusion ...

Clinical trials have demonstrated that the drug can delay deterioration by four to six months, targeting the beta-amyloid ...

Antimicrobials, vaccines, and anti-inflammatories are associated with a reduced risk for Alzheimer disease and dementia.

Drugs targeting amyloid plaques have failed to show efficacy in clinical trials. A new approach is needed to tackle AD ...

Demand for the latest Alzheimer’s drugs is now “astronomical”, Dr ... of Alzheimer’s disease is going to be on a clinical trial. They’re not going to be sitting at home.

Two new PET radiotracers have outperformed the only current Food and Drug Administration (FDA) approved radiotracer for ...

A simple blood test that could revolutionise dementia diagnosis has started trials in NHS clinics ... "There is a whole load of drugs under development that are likely to be licensed and ...